• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXHL0900165 YM178缓释片 mirabegron Tablet, extended release Chemical Drugs Import Drug Application 2009-05-21 Astellas Pharma Global Development, Inc. Astellas Pharma Global Development Inc Certificate Issued 2010-03-05 view
JXHL1300265 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs Import Drug Application 2013-07-31 安斯泰来制药(中国)有限公司 Astellas Pharmaceutical (China) Co Ltd;Astellas Pharma Europe BV Certificate Issued 2015-12-03 view
CYHS2302038 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs(4) Generic Drug 2023-07-31 Guangzhou Bositao Controlled Release Pharmaceutical Co Ltd;Chongqing Pharmaceutical (GROUP) Co Ltd view
JYHB2001376 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs Supplementary Application 2020-08-21 安斯泰来制药(中国)有限公司 Astellas Pharmaceutical (China) Co Ltd;Avara Pharmaceutical Technologies Inc;Astellas Pharma Europe BV Filed 2020-09-02 view
CXHL1402291 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs(3.1) New Drug Application 2015-03-13 南京海融医药科技有限公司 Nanjing Heron Pharmaceutical Science and Technology Co Ltd Certificate Issued 2016-05-31 view
CYHB2401219 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs(4) Supplementary Application 2024-08-09 QILU Pharmaceutical Co Ltd view
CYHS2200740 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs(4) Generic Drug 2022-05-24 Sunshine Lake Pharma Co Ltd view
JYHB1701346 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs Supplementary Application 2017-10-28 安斯泰来制药(中国)有限公司 Astellas Pharmaceutical (China) Co Ltd;Avara Pharmaceutical Technologies Inc;Astellas Pharma Europe BV Certificate Issued 2017-12-26 view
JYHB2300103 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs Supplementary Application 2023-02-08 Avara Pharmaceutical Technologies Inc;Astellas Pharma Europe BV view
JYHB1801111 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs Supplementary Application 2018-09-18 安斯泰来制药(中国)有限公司 Astellas Pharmaceutical (China) Co Ltd;Avara Pharmaceutical Technologies Inc;Astellas Pharma Europe BV Filed 2018-09-20 view
CXHL1401277 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs(3.1) New Drug Application 2014-10-20 南京华威医药科技开发有限公司 Nanjing Huawei Medicine Technology Development Co Ltd Certificate Issued 2016-03-24 view
CYHS2303421 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs(4) Generic Drug 2023-12-09 Jiangsu Deyuan Pharmaceutical Co Ltd view
CYHS2201902 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs(4) Generic Drug 2022-11-08 China Resources SAIKE Pharmaceutical Co Ltd view
CXHL1501916 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs(3.1) New Drug Application 2015-10-13 江苏德源药业股份有限公司 Jiangsu Deyuan Pharmaceutical Co Ltd Certificate Issued 2016-10-11 view
CYHS2102142 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs(4) Generic Drug 2021-12-06 QILU Pharmaceutical Co Ltd view
JYHF1800006 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs Supplementary Application 2018-01-26 安斯泰来制药(中国)有限公司 Astellas Pharmaceutical (China) Co Ltd;Avara Pharmaceutical Technologies Inc;Astellas Pharma Europe BV Certificate Issued 2018-02-28 view
CYHS1900699 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs(4) Generic Drug 2019-10-16 杭州华东医药集团浙江华义制药有限公司 Zhejiang Huayi Pharmaceutical Co Ltd Certificate Issued 2021-04-20 view
CXHL1401864 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs(3.1) New Drug Application 2015-02-16 瑞阳制药有限公司 Reyoung Pharmaceutical Co Ltd Certificate Issued 2016-05-19 view
CYHS2401877 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs(4) Generic Drug 2024-06-25 Chengdu Kanghong Pharmaceutical Group Co Ltd view
JYHZ2100672 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs License Renew 2021-10-28 Avara Pharmaceutical Technologies Inc;Astellas Pharma Europe BV view